The European Sting is Your democratic, independent and top quality political newspaper specialized in European Union News. Unique Features: iSting & Harry Sting
This article is brought to you in association with the European Commission. The European Commission has unconditionally approved the proposed acquisition of Seagen by Pfizer, under the EU Merger Regulation. The Commission concluded that the transaction would not raise competition concerns in the European Economic Area (‘EEA’). Seagen and Pfizer are pharmaceutical companies. Seagen specialises in […]
This article is brought to you in association with the European Commission. Today, the European Commission, acting with and on behalf of EU Member States through the Health Emergency Preparedness and Response Authority (HERA), and vaccine developers BioNTech-Pfizer, have reached an agreement to better address Member States’ assessment of evolving needs for COVID-19 vaccines. The amendment […]
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Kate Whiting, Senior Writer, Formative Content The EU has cleared Pfizer’s oral COVID pill for use to prevent hospitalization and death from COVID-19. It’s just one of many COVID-19 treatments in development. Merck’s oral antiviral molnupiravir became the […]
This article is brought to you in association with the European Commission. The Commission and BioNTech-Pfizer have come to an agreement on the accelerated delivery of 10 million doses for Quarter 2. Commission President Ursula von der Leyen said: “I know how critical Quarter 2 is for the roll-out of our vaccination strategies in the Member […]
This article is brought to you in association with the European Commission. The European Commission has reached an agreement with BioNTech-Pfizer for the supply of four million more doses of COVID-19 vaccines for Member States in the next two weeks in order to tackle coronavirus hotspots and to facilitate free border movement. The President of the […]
This article is brought to you in association with the European Commission. The European Commission has approved, under the EU Merger Regulation, the proposed merger between the global pharmaceutical company Mylan and Upjohn, a business division of Pfizer, which operates Pfizer’s off-patent branded and generic established medicines. The decision is conditional on the divestment of Mylan’s […]
This article is brought to you in association with the European Commission. The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer’s Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer’s topical pain management business carried out under the ThermaCare brand. GlaxoSmithKline (“GSK”) and Pfizer’s Consumer Health Business […]
Pharmaceutical firms in Europe have an awkward relation with their customers. The truth is that their selling prices and product licencing are directly or indirectly controlled by the buyers, that is governments, or government control health insurance schemes, offering almost free health services to citizens. As everybody knows governments are not only able to influence […]
